In 2003, the Bush administration also changed its position and concluded that generic treatment could indeed be part of an effective HIV strategy. Bush created the PEPFRR program, which received $15 billion from 2003 to 2007 and was re-enacted in 2008 for $48 billion over the next five years. Despite the difficulties related to the issue of compulsory licensing, THE PFPR began marketing generic drugs in 2004-5. (iii) The country may impose discriminatory restrictions on products that have not previously been subject to GATT or WAT rules or that are not subject to the current bilateral administration. This is the time when countries like the United States threaten to secede from the WTO, which neutralizes the WTO, which can provide a solid basis for a strong WTO by protecting the interests of India and other emerging economies like Brazil, South Africa, etc. . . .
- September 10, 2021